POIA
CELU icon

Pin Oak Investment Advisors’s Celularity CELU Stock Holding History

Pin Oak Investment Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$3K – 415
2022
Q1 		$3K Buy
+40
New +$2.4K ﹤0.01% 383

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Pin Oak Investment Advisors's CELU Position: Q2 2022 in Review

Pin Oak Investment Advisors sold out of Celularity (CELU) in Q2 2022, closing a stake of 40 shares — an estimated $3K sold.

Pin Oak Investment Advisors first reported a position in CELU in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 66 funds tracked by Wall St. Rank hold CELU as of Q2 2022.

  • Pin Oak Investment Advisors reported no remaining Celularity position as of Q2 2022 after selling out during the quarter.
  • Pin Oak Investment Advisors sold 40 Celularity shares in Q2 2022, an estimated $3K.
  • Pin Oak Investment Advisors first reported a position in Celularity in Q1 2022 and held it in 1 quarter.
  • Pin Oak Investment Advisors's Celularity position peaked at $3K in Q1 2022.
  • 66 funds tracked by Wall St. Rank held Celularity as of Q2 2022.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.